oligoadenyl
synthetas
antivir
proapoptot
antiprolif
gene
convert
atp
seri
oligoadenyl
turn
activ
rnasel
candid
hereditari
prostat
cancer
gene
polymorph
associ
increas
suscept
infect
variou
diseas
gener
low
enzym
activ
aa
genotyp
promot
suscept
wherea
high
enzym
activ
gg
genotyp
confer
protect
studi
investig
associ
function
polymorph
prostat
cancer
methodssampl
size
power
calcul
use
pga
softwar
genom
dna
control
prostat
cancer
patient
use
genotyp
snp
sampl
statist
analysi
perform
use
logist
regress
model
resultssignific
associ
observ
genotyp
ag
prostat
cancer
genotyp
aa
increas
risk
wherea
gg
genotyp
decreas
risk
prostat
cancer
gg
genotyp
observ
african
american
sampl
aa
genotyp
also
increas
risk
prostat
cancer
age
snp
aa
genotyp
significantli
associ
prostat
cancer
wherea
gg
genotyp
protect
prostat
cancer
could
prostat
cancer
suscept
polymorph
signific
observ
especi
context
pathway
thu
function
defect
due
snp
attenu
rnasel
function
also
alter
cell
growth
apoptosi
independ
rnasel
oligoadenyl
synthetas
extens
character
enzym
induc
interferon
ifn
requir
effect
antivir
respons
presenc
doubl
strand
rna
structur
viral
genom
singl
strand
rna
transcript
possess
signific
doubl
strand
charact
convert
atp
seri
oligoadenyl
one
primari
function
promot
dimer
latent
ribonucleas
rnasel
form
catalyt
activ
rnasel
activ
system
promot
apoptosi
attenu
prolifer
degrad
viral
cellular
rna
inhibit
protein
synthesi
oa
also
shown
affect
cellular
event
independ
rnasel
antivir
activ
cell
growth
differenti
evid
also
demonstr
proapoptot
activ
isoform
vitro
interact
bclxl
epidemiolog
studi
linkag
analysi
associ
base
studi
posit
clone
candid
gene
approach
led
identif
rnasel
candid
hereditari
prostat
cancer
gene
experiment
studi
also
shown
activ
rnasel
degrad
viral
genom
also
antiprolif
promot
senesc
apoptosi
prostat
cancer
cell
thu
act
true
tumor
suppressor
howev
follow
studi
sever
group
identifi
signific
number
rnasel
germlin
variant
among
famili
hereditari
prostat
cancer
moreov
signific
associ
rnasel
mutat
polymorph
sporad
prostat
cancer
observ
observ
led
us
believ
altern
mechan
pathway
lead
activ
express
rnasel
could
involv
prostat
cell
one
mechan
pathway
may
possibl
level
rate
limit
enzym
rnasel
activ
thu
defect
possibl
attenu
rnasel
function
also
alter
cell
growth
apoptosi
rnasel
independ
manner
singl
nucleotid
polymorph
known
modul
function
multipl
level
includ
express
altern
splice
enzym
activ
total
ucsc
genom
databas
ncbi
dbsnp
databas
polymorph
marker
known
exist
gene
two
function
nonsynonym
polymorph
marker
well
studi
demonstr
associ
variou
diseas
suscept
hepat
c
viru
influenza
viru
flaviviru
west
nile
viru
respiratori
epitheli
cell
syncyti
viru
ocular
herp
simplex
viru
type
sar
polymorph
also
increas
suscept
multipl
sclerosi
type
diabet
interestingli
ag
singlenucleotid
polymorph
g
near
exon
spliceacceptor
site
gene
known
alter
enzym
activ
enzym
activ
highest
individu
gg
genotyp
intermedi
ag
genotyp
lowest
aa
genotyp
collect
observ
led
us
investig
hypothesi
function
polymorph
specif
could
associ
prostat
cancer
result
demonstr
polymorph
associ
prostat
cancer
specif
genotyp
may
confer
decreas
suscept
prostat
cancer
prostat
cancer
cell
line
lncap
purchas
cultur
per
instruct
atcc
genotyp
protocol
use
human
sampl
studi
approv
irb
clark
atlanta
univers
genotyp
perform
total
sampl
cancer
control
constitut
approxim
total
sampl
set
tabl
retrospect
collect
buffi
coat
sampl
obtain
biospecimen
share
resourc
ku
cancer
center
univers
kansa
medic
centr
cooper
human
tissu
network
chtn
southern
divis
follow
appropri
protocol
review
approv
purifi
genom
dna
sampl
obtain
commerci
bioserv
inc
beltsvil
md
sampl
store
analysi
deidentifi
comprehens
clinic
inform
regard
age
ethnic
stage
avail
sampl
ethnic
sampl
report
vendor
specif
admixtur
analysi
perform
howev
famili
histori
prostat
cancer
psa
level
gleason
score
avail
sampl
henc
includ
final
statist
analysi
genom
dna
isol
store
cultur
cell
buffi
coat
use
aquapur
total
genom
dna
isol
kit
biorad
averag
approxim
dna
routin
isol
buffi
coat
total
rna
cultur
cell
isol
use
trizol
invitrogen
method
final
rna
pellet
wash
ethanol
air
dri
resuspend
diethylpyrocarbon
depc
treat
concentr
mgml
store
analysi
one
ug
total
rna
revers
transcrib
use
mmlvrt
promega
total
volum
per
manufactur
instruct
rtpcr
perform
use
follow
gene
specif
primer
forward
cgg
tct
atg
ctt
ggg
ag
revers
gat
gca
ctg
gca
ttc
ag
reaction
use
gotaq
colorless
master
mix
promega
primer
revers
transcrib
rna
genom
pcr
carri
pcr
reaction
consist
gotaq
colorless
master
mix
promega
genom
dna
primer
pcr
carri
cycl
anneal
temperatur
respect
follow
primer
use
ref
total
protein
cultur
prostat
cancer
cell
extract
use
mper
pierc
contain
appropri
proteas
inhibitor
complet
mini
roch
total
protein
concentr
determin
bradford
method
twenti
microgram
total
protein
separ
sd
polyacrylamid
gel
blot
onto
nitrocellulos
membran
biorad
ca
western
blot
analysi
perform
use
protein
specif
antibodi
goat
antihuman
santa
cruz
actin
rabbit
antihuman
santa
cruz
ca
primari
antibodi
detect
donkey
antigoat
hrp
antirabbit
igg
hrp
conjug
upstat
ca
respect
hrp
detect
ecl
pierc
il
blot
visual
use
fuji
film
imag
polymorph
detect
sequenc
pcr
amplicon
span
state
snp
use
primer
pair
indic
aliquot
respect
pcr
reaction
first
analyz
agaros
gel
confirm
specif
qualiti
reaction
term
band
size
absenc
background
pcr
product
confirm
remain
pcr
product
clean
use
exosapit
usb
sequenc
ab
sequenc
dna
sequenc
lab
morehous
school
medicin
atlanta
ga
sequenc
perform
use
primer
case
nest
primer
within
pcr
product
sequenc
scan
use
abi
sequenc
scanner
snp
manual
detect
amplicon
show
low
qualiti
read
resequenc
singl
nucleotid
polymorph
also
detect
snpdetctor
ensur
snp
due
heterozyg
allel
variat
due
sequenc
artifact
sequenc
align
ncbi
refer
sequenc
clustal
w
also
use
valid
respect
sequenc
read
sampl
size
requir
achiev
statist
signific
associ
calcul
use
power
calcul
case
control
genet
associ
studi
pga
paramet
use
sampl
size
calcul
follow
power
prostat
cancer
diseas
preval
men
actual
race
white
black
per
men
respect
per
seer
aa
genotyp
diseas
frequenc
chosen
diseas
allel
frequenc
base
variabl
pga
estim
sampl
size
case
actual
sampl
size
would
lower
exact
prostat
cancer
diseas
preval
number
base
calcul
select
sampl
size
approxim
time
estim
pga
polymorph
test
associ
prostat
cancer
odd
ratio
confid
interv
calcul
genotyp
associ
prostat
cancer
use
logist
regress
analysi
adjust
age
relationship
genotyp
distribut
subject
stratifi
race
age
also
analyz
use
model
ncss
version
version
sigmastat
use
statist
analysi
sampl
size
calcul
power
calcul
use
power
genet
associ
analys
pga
packag
matlab
avail
nation
cancer
institut
websit
stratifi
data
age
group
race
regular
logist
regress
model
use
calcul
odd
ratio
confid
interv
ci
use
control
group
refer
logist
regress
model
also
use
assess
interact
age
genotyp
case
group
detect
differenti
effect
differ
age
interv
p
consid
statist
signific
gene
give
rise
three
altern
splice
protein
isoform
primarili
ctermin
end
vari
molecular
weight
shown
fig
snp
exon
c
rd
exon
present
three
isoform
snp
howev
present
isoform
isoform
wherea
isoform
present
toward
cterm
end
protein
isoform
isoform
nonsynonym
result
amino
acid
chang
respect
outlin
fig
order
establish
rational
investig
associ
polymorph
prostat
cancer
first
investig
express
establish
prostat
cancer
cell
line
express
observ
transcript
protein
level
cell
fig
lncap
cell
occasion
observ
transcript
protein
detect
western
blot
fig
inconsist
transcript
level
could
due
altern
splice
might
result
prematur
termin
peptid
lncap
cell
fig
genotyp
cell
line
snp
studi
follow
ag
three
cell
line
rs
lncapgg
aa
cc
three
cell
line
retrospect
casecontrol
studi
sampl
perform
analysi
polymorph
unrel
clinic
defin
cancer
control
sampl
roughli
total
sampl
popul
mean
age
cancer
sampl
normal
sampl
age
match
sampl
popul
mixtur
caucasian
african
american
tabl
frequenc
previous
genotyp
normal
sampl
set
consist
report
control
popul
allel
frequenc
conform
hardi
weinberg
equilibrium
caucasian
popul
chi
due
lack
gg
genotyp
minor
allel
mark
deviat
hw
equilibrium
african
american
subject
observ
frequenc
distribut
complet
sampl
stratifi
sampl
set
list
tabl
ii
iii
respect
combin
cancer
control
group
reveal
aa
major
wherea
gg
minor
genotyp
tabl
ii
aa
genotyp
overrepres
cancer
vs
control
ratio
wherea
ag
genotyp
distribut
essenti
similar
cancer
normal
group
tabl
ii
contrari
aa
genotyp
distribut
gg
genotyp
overrepres
normal
group
compar
cancer
tabl
ii
sampl
stratif
demonstr
genotyp
distribut
associ
race
aa
genotyp
overrepres
african
american
group
vs
caucasian
wherea
ag
vs
caucasian
gg
vs
caucasian
genotyp
overrepres
caucasian
group
genotyp
distribut
suggest
g
allel
significantli
underrepres
african
american
wherea
allel
repres
african
american
comprehens
statist
analysi
reveal
subject
combin
sampl
aa
genotyp
time
like
develop
prostat
cancer
genotyp
tabl
ii
logist
regress
analysi
also
suggest
increas
risk
prostat
cancer
aa
genotyp
genotyp
fig
result
consist
african
american
tabl
ii
caucasian
group
tabl
ii
suggest
irrespect
race
genotyp
aa
strongli
associ
prostat
cancer
convers
gg
genotyp
reduc
incid
prostat
cancer
fold
p
tabl
ii
compar
ag
gg
genotyp
convert
probabl
term
suggest
presenc
gg
genotyp
reduc
incid
prostat
cancer
use
genotyp
base
age
group
ag
genotyp
found
risk
factor
analyz
context
sampl
within
caucasian
popul
statist
analysi
also
examin
effect
age
incid
prostat
cancer
data
stratif
age
demonstr
year
age
incid
prostat
cancer
fold
higher
previou
decadebut
likelihood
number
jump
decad
aa
genotyp
therefor
increas
age
aa
genotyp
significantli
increas
prostat
cancer
incid
compar
effect
age
alon
prostat
cancer
fig
signific
associ
g
observ
prostat
cancer
tabl
iii
genotyp
observ
analyz
sequenc
genotyp
c
upstream
intron
tabl
iv
statist
analysi
fail
demonstr
signific
associ
prostat
cancer
either
tabl
iv
howev
confirm
hw
equilibrium
ethnic
dispar
observ
genotyp
distribut
studi
report
first
time
associ
polymorph
prostat
cancer
import
part
total
constitut
activ
oa
enzym
activ
rate
limit
enzym
determin
rnasel
antivir
tumor
suppressor
activ
recent
studi
demonstr
also
promot
apoptosi
act
antivir
agent
independ
rnasel
via
paracrin
mechan
thu
emerg
multifunct
protein
involv
innat
immun
respons
also
potent
tumor
suppressor
studi
select
two
function
polymorph
marker
associ
diseas
viral
infect
gener
aa
genotyp
promot
diseas
suscept
wherea
gg
genotyp
confer
protect
sarscov
infect
multipl
sclerosi
ms
possibl
aa
ag
gg
genotyp
result
lowest
intermedi
highest
enzym
activ
respect
consist
observ
genotyp
aa
appear
risk
factor
prostat
cancer
increas
risk
wherea
higher
activ
genotyp
gg
protect
prostat
cancer
lower
risk
allel
also
signific
risk
factor
age
prostat
cancer
logist
regress
model
age
risk
factor
prostat
cancer
expect
howev
aa
genotyp
increas
odd
prostat
cancer
incid
absenc
homozyg
gg
genotyp
african
american
popul
essenti
consist
popul
wide
genotyp
distribut
report
ncbi
dbsnp
databas
analysi
ncbi
dbsnp
databas
reveal
gg
genotyp
absent
african
american
subsaharan
african
popul
gg
genotyp
absent
african
america
sampl
afdafrpanel
subsaharan
african
sampl
hapmapyri
frequenc
g
allel
african
american
set
aodafricanamerican
compar
frequenc
exclus
ag
genotyp
normal
african
american
sampl
set
tabl
ii
thu
least
three
independ
studi
perform
three
differ
platform
perlegen
abi
xplore
sequenc
base
analysi
two
divers
popul
demonstr
lack
gg
genotyp
subject
african
ethnic
subsaharan
african
american
result
suggest
polymorph
perhap
splice
variant
could
genet
determin
african
american
surprisingli
gg
genotyp
observ
caucasian
sampl
set
frequenc
heavili
bias
favor
normal
caucasian
normal
vs
cancer
p
contrast
aa
genotyp
associ
prostat
cancer
high
african
american
compar
caucasian
sake
breviti
may
propos
higher
incid
prostat
cancer
african
american
could
due
lack
gg
genotyp
howev
larger
cohort
specif
biolog
endpoint
measur
effect
genotyp
express
enzym
activ
apoptosi
prolifer
yet
unknown
biolog
activ
need
support
statement
genotyp
linkag
disequilibrium
ld
g
allel
govern
splice
last
exon
exon
harbor
gg
genotyp
retain
splice
site
result
high
enzym
activ
wherea
aa
genotyp
disrupt
splice
site
lead
low
enzym
activ
due
alter
splice
three
genotyp
reportedli
gener
differ
isoform
gg
ag
aa
isoform
ident
exon
diverg
exon
expect
two
transcript
correspond
isoform
observ
prostat
cancer
cell
line
harbor
ag
genotyp
use
primer
pair
span
exon
surprisingli
lncap
cell
also
heterozyg
ag
genotyp
express
splice
variant
suggest
splice
event
exon
exon
addit
also
linkag
disequilibrium
exon
interest
investig
propos
ld
exist
block
prostat
cancer
cell
sampl
set
previous
evolutionari
conserv
exon
also
nonsynonym
allel
result
amino
acid
chang
close
dsrna
bind
domain
isoform
polymorph
suggest
function
genet
studi
type
diabet
possibl
due
congenit
rubella
viru
infect
data
set
statist
signific
associ
observ
genotyp
racial
distribut
prostat
cancer
collect
associ
studi
data
stratif
present
studi
suggest
specif
associ
prostat
cancer
signific
racial
dispar
age
prostat
cancer
caus
multipl
gene
possibl
interact
complex
biolog
pathway
influenc
environment
factor
pathway
fit
gener
hypothesi
irrespect
rnasel
mutat
express
low
lack
activ
attenu
rnasel
action
subsequ
host
innat
immun
respons
tumor
suppress
thu
polymorph
alter
activ
modul
effect
higherrisk
suscept
gene
rnasel
respons
hereditari
prostat
cancer
could
also
promot
sporad
prostat
cancer
independ
studi
investig
associ
function
polymorph
prostat
cancer
result
suggest
aa
genotyp
significantli
associ
prostat
cancer
wherea
gg
genotyp
protect
prostat
cancer
fund
support
nih
ncmhd
support
core
facil
sharedaddit
resourc
fund
part
nihncrrrcmi
structur
polymorph
express
panel
structur
gene
show
isoform
exon
design
e
last
exon
isoform
label
nonsynonym
singl
nucleotid
polymorph
nucleotid
g
protein
g
appear
isoform
singl
nucleotid
polymorph
g
locat
last
exon
isoform
result
g
r
amino
acid
isoform
singl
nucleotid
polymorph
c
intron
exon
b
c
panel
b
typic
rflp
use
confirm
snp
restrict
digest
amplifi
genom
pcr
fragment
use
primer
pair
indic
materi
method
panel
c
revers
transcriptas
polymeras
chain
reaction
mrna
isol
lncap
cell
use
primer
pair
indic
materi
method
primer
design
differenti
amplifi
isoform
result
approxim
band
respect
panel
protein
express
prostat
cancer
cell
line
western
blot
analysi
whole
cell
lysat
use
western
blot
analysi
use
antibodi
load
control
pcr
western
blot
shown
repres
least
experi
panel
probabl
particular
genotyp
prostat
cancer
calcul
logist
regress
model
p
case
genotyp
genotyp
use
depend
variabl
calcul
associ
prostat
cancer
logist
regress
model
graph
show
probabl
model
express
percentag
base
model
aa
genotyp
increas
risk
prostat
cancer
compar
genotyp
genotyp
ag
neutral
risk
prostat
cancer
neither
increas
decreas
risk
prostat
cancer
genotyp
gg
decreas
risk
prostat
cancer
panel
b
effect
age
genotyp
aa
prostat
cancer
prostat
cancer
incid
increas
age
shown
increas
odd
ratio
oronli
age
effect
genotyp
aa
addit
effect
prostat
cancer
incid
orag
aa
effect
associ
snp
prostat
cancer
genotyp
distribut
sampl
caucasian
sampl
africanamerican
sampl
correspond
odd
ratio
confid
interv
p
valu
shown
